on a mobile?
vTap
    Loading...
 
 
Video
...atrial fibrillation in patients with heart failure, alemtuzumab vs. interferon beta-1a in early multiple sclerosis, cardiovascular outcomes after a change in prescription policy for clopidogrel, ...
25m 16s |
a month ago
EveryZing
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Fred Hutchinson Cancer Research Center
Colorectal cancer
Nick Harper
Cetuximab
New England Journal of Medicine
New England
Go to Feed to see what's new!
share
keep
 
 
...is and lymphadenopathy; and Perspective articles on trying times at the FDA regarding the safety of imported pharmaceuticals, on playing "Kick the FDA", and on eliminating blinding trachoma. show ...
25m 43s |
7 months ago
EveryZing
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Biomedical research
Coronary artery bypass surgery
United States
Stent
Lung cancer
Coronary circulation
New England
New England Journal of Medicine
Dietary supplement
Go to Feed to see what's new!
share
keep
 
 
According to a study in this week's New England Journal of Medicine, arthritis supplements may work better than we thought, even when you stack them up against prescription arthritis medication.
2 years ago
CBS (cbs4 - Denver)
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
New England Journal of Medicine
Diet (nutrition)
Prescription drug
Health care
Katie Hnida
Go to Feed to see what's new!
share
keep
 
 
This week's issue of the New England Journal of Medicine highlights a report by the Cleveland Clinic, which concludes that patients undergoing cardiac surgery have an increased risk of complications ...
8 months ago
KEYC Television
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Cleveland Clinic
United States
New England Journal of Medicine
Go to Feed to see what's new!
share
keep
 
 
...NEJM) ...pharmaceutical company recently started Phase I clinical trials of a myostatin blocker to treat muscle-wasting diseases. In Phase I trials the drug is tested for safety in healthy adults. ...
1m 26s |
4 years ago
Science Central
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Gene doping
Scientist
Human enhancement
Go to Feed to see what's new!
share
keep
 
 
More Videos
 
Keep this video in the "Saved" list
Go to Feed to see what's new!
share
keep
 
 
 
 
This summary covers the issue of June 19, 2008. Featured are articles on rhythm control versus rate control for atrial fibrillation and heart failure, increased mortality after dronedarone therapy for severe heart failure, electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1, treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1, over-the-counter sales of drugs for asymptomatic conditions, and on tumor necrosis factor α and colitis-associated colon cancer; a review article on cancer immunology; a case report of an HIV-positive man with cutaneous Merkel-cell carcinoma; and Perspective articles on the Genetic Information Nondiscrimination Act of 2008 and on cancer immunotherapy. show less
19m 40s |
5 months ago
EveryZing
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Ortho-McNeil Pharmaceutical
Pharmaceutical company
New England Journal of Medicine
New England
Go to Feed to see what's new!
share
keep
 
 

Corporate Home Corporate Home News FAQ About Contact Forums Send Feedback
Privacy Policy and Terms of Use